June 3, 2026
CMIC HOLDINGS Co., Ltd.
CMIC HOLDINGS Reaches Agreement with SGS to Transfer All Shares of CMIC, INC.
— Advancing Global Bioanalytical Capabilities through Strategic Collaboration —
CMIC HOLDINGS Co., Ltd. (“CMIC Holdings”) announced today that it has entered into an agreement to transfer all outstanding shares of CMIC, Inc., a subsidiary of CMIC HOLDINGS group company engaged in bioanalysis operations in Chicago, Illinois, USA, to SGS NORTH AMERICA INC., a global leader in the Testing, Inspection, and Certification (TIC) industry.
Established in 2010, CMIC, INC. has been supporting the research and development of biopharmaceuticals and advanced therapies for pharmaceutical and biotechnology companies in North America. Operating a 27,000-square-foot GLP-compliant facility, the company provides small and large molecule bioanalytical testing services from the preclinical to clinical stages. Leveraging its extensive expertise in nucleic acid therapeutics analysis, CMIC, INC. has delivered seamless value to clients in both Japan and the United States.
Going forward, through collaboration between CMIC Pharma Science Co., Ltd., a consolidated subsidiary of CMIC HOLDINGS operating bioanalysis laboratories in Japan, and SGS NORTH AMERICA, the companies will maintain and further strengthen a bioanalytical testing framework that ensures consistent quality standards across both Japan and the United States.
Through this global collaboration, CMIC HOLDINGS and SGS aim to enhance their bioanalytical service offerings and support the growing and increasingly complex needs of the pharmaceutical and biotechnology industries worldwide.
About SGS
SGS is the world’s leading Testing, Inspection and Certification company. We operate a network of over 2,500 laboratories and business facilities across 115 countries, supported by a team of over 100,000 dedicated professionals. With more than 145 years of service excellence, we combine the precision and accuracy that define Swiss companies to help organizations achieve the highest standards of quality, compliance and sustainability.
Our brand promise – when you need to be sure – underscores our commitment to trust, integrity and reliability, enabling businesses to thrive with confidence. We proudly deliver our expert services through the SGS name and a portfolio of trusted specialized brands, including Applied Technical Services, Brightsight, Bluesign and Nutrasource.
SGS is publicly traded on the SIX Swiss Exchange under the ticker symbol SGSN (ISIN CH1256740924, Reuters SGSN.S, Bloomberg SGSN SW).
About CMIC, INC.
CMIC, INC. is a non-clinical Contract Research Organization (CRO) based in the Chicago metropolitan area in the state of Illinois, USA, specializing in the quantitative analysis of drug concentrations in biological samples as well as the measurement of various biomarkers. Founded in 2010, the company provides bioanalytical testing services spanning from preclinical to clinical phases, supported by GLP-compliant facilities.
Equipped with state-of-the-art analytical instruments and a robust operational framework, CMIC, INC. offers end-to-end services—from sample receipt and analysis to data reporting—enabling rapid turnaround times and the ability to manage large-scale studies efficiently.
In addition, through close collaboration with CMIC Pharma Science Co., Ltd., an analytical laboratory based in Japan, CMIC, INC. has established a comprehensive operational structure that ensures smooth communication and seamless execution of studies conducted between Japan and the United States.
About CMIC Group
CMIC Group launched Japan’s first CRO business in 1992 and now provides comprehensive support for pharmaceuticals—from development and manufacturing to sales and marketing. The Group supports overseas companies entering the Japanese market, conducts clinical trials in Asia, and provides development and manufacturing support in the U.S. and Japan. CMIC Group also provides new healthcare solutions that support individuals and local governments, and aims to expand its PHVC (“Personal Health Value Creator”) model, which focuses on maximizing personal health value. The Group consists of 28 companies and more than 7,700 employees worldwide. For more information about CMIC Group, visit: https://en.cmicgroup.com/
